**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 90-11-9 |1-Bromonaphthalene | >96 | 201-965-2 |
|----------------|--------------------------------------|----------|-----------|
| 580-13-2 |2-Bromonaphthalene | < 2 | 209-452-5 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN
Risk Phrases: 22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed.The toxicological properties of this material
have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. Naphthalene is an eye irritant. The
vapor causes eye irritation at 15 ppm. Eye contact with the solid
material may result in conjunctivitis, superficial injury to the
cornea, diminished visual acuity, and other effects. It may cause
cataracts.
Skin:
May cause skin irritation. May be harmful if absorbed through the
skin. The toxicological properties of this material have not been
fully investigated.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with
nausea, vomiting and diarrhea. The toxicological properties of this
substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated. May be harmful if
inhaled.
Chronic:
Chronic inhalation, skin absorption or ingestion of naphthalene have
caused severe hemolytic anemia.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid if cough or other symptoms appear.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Vapors may be heavier
than air. They can spread along the ground and collect in low or
confined areas. Containers may explode when heated.
Extinguishing Media:
Cool containers with flooding quantities of water until well after
fire is out. Use water spray, dry chemical, carbon dioxide, or
appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Avoid contact with
eyes, skin, and clothing. Keep container tightly closed. Avoid
ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 90-11-9:
CAS# 580-13-2:
Personal Protective Equipment
Eyes:
Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear yellow
Odor: strong odor - naphthalene-like
pH: Not available.
Vapor Pressure: 0.017 mm Hg @ 20 deg C
Viscosity: Not available.
Boiling Point: 279-281 deg C
Freezing/Melting Point: -1 deg C
Autoignition Temperature: Not available.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Slightly soluble.
Specific Gravity/Density: 1.48
Molecular Formula: C10H7Br
Molecular Weight: 207.07
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Light, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 90-11-9: QJ1545000
CAS# 580-13-2 unlisted.
LD50/LC50:
CAS# 90-11-9: Oral, rat: LD50 = 810 mg/kg.
CAS# 580-13-2.
Carcinogenicity:
1-Bromonaphthalene -
Not listed by ACGIH, IARC, or NTP.
2-Bromonaphthalene -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 90-11-9: No information available.
CAS# 580-13-2: No information available.
Canada
CAS# 90-11-9 is listed on Canada's DSL List.
CAS# 580-13-2 is listed on Canada's NDSL List.
CAS# 90-11-9 is not listed on Canada's Ingredient Disclosure List.
CAS# 580-13-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 90-11-9 is listed on the TSCA inventory.
CAS# 580-13-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 11/05/1998 Revision #6 Date: 4/29/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
6-Amino-2-Naphthoic Acid, 90%
| 11668-47-4 |
|
Zirconium (IV) Oxide, P.A.
| 1314-23-4 |
|
cis-Dichlorodiamineplatinum(II), 99.99%
| 15663-27-1 |
|
1-Bromonaphthalene 96%, contains max. 2% 2-bromonaphthalene
| 90-11-9 |
|
1-Heptanesulfonic acid, sodium salt, monohydrate, HPLC grade
| 207300-90-1 |
|
1-Hexanesulfonic acid sodium salt, HPLC grade
| 2832-45-3 |
|
5-Bromo-1-pentene, 96%
| 1119-51-3 |
|
2,6-Diphenylphenol
| 2432-11-3 |
|
L-Cystine
| 56-89-3 |
|
1-Pentanesulfonic Acid, Sodium Salt Monohydrate, HPLC Grade
| 22767-49-3 |
|
1,1,2-Trichloroethane Density Standard
| 79-00-5 |
|
2-Ethoxyethanol, 99%
| 110-80-5 |
|
Antimony Trichloride
| 10025-91-9 |
|
2-Ethoxyethyl acetate 99%
| 111-15-9 |
|
DL-2-Octanol, 97%
| 123-96-6 |
|
2,2,2-Trifluoroethanol
| 75-89-8 |
|
5-Amino-2-methylindole, 98%
| 7570-49-2 |
|
Bromoacetaldehyde Diethyl Acetal, 97%
| 2032-35-1 |
|
2-Acetylcyclohexanone, 97%
| 874-23-7 |
|
Lauric acid, 98%
| 143-07-7 |
|
4-Methoxy-2-nitroaniline, 98%
| 96-96-8 |
|
1-Nitroso-2-naphthol-3,6-disulfonic acid disodium salt
| 0-00-0 |
|
Toluidine Blue O Zinc Chloride Double Salt
| 0-01-1 |
|
2,4,6-Triphenylpyrylium Chloride, 90%
| 40836-01-9 |
|
2-Isopropoxyethanol, 98%
| 109-59-1 |
|
2,6-Difluorobenzoyl Isocyanate
| 60731-73-9 |
|
1-(4-Chlorophenyl)-1-Cyclopropane- Carboxylic Acid, 99%
| 72934-37-3 |
|
1-Bromo-1-propene, mixture of isomers, 95%
| 590-14-7 |
|
3-Aminopyrrolidine Dihydrochloride
| 103831-11-4 |
|
2,2,4-Trimethylpentane, p.a.
| 540-84-1 |
|
Phenyl Salicylate, 99% (UV-Vis)
| 118-55-8 |
|
MOPS
| 1132-61-2 |
|
P-Naphtholbenzein, 90+% (UV-VIS)
| 145-50-6 |
|
1-Amino-4-Hydroxyanthraquinone, 96%
| 116-85-8 |
|
4-Aminoantipyrine, 98%
| 83-07-8 |
|
Sodium metatungstate, 2.82 density solution in water, stabilized
| 7732-18-5 |
|
8-Hydroxyquinoline, p.a.
| 148-24-3 |
|
3-Methyl-2-Cyclohexen-1-One, 98%
| 1193-18-6 |
|
Cerium(IV) sulfate tetrahydrate
| 10294-42-5 |
|
Sodium metatungstate hydrate, crystalline
| 12141-67-2 |
|
O-Methylbenzyl Cyanide, 98%
| 22364-68-7 |
|
l(-)-Glutathione, oxidized, hydrate, 95%
| 27025-41-8 |
|
Antimony Trioxide
| 1309-64-4 |
|
Dibutyl L-Tartrate
| 87-92-3 |
|
(-)-Terpinen-4-ol, 97%
| 562-74-3 |
|
3,5-Dinitrosalicylic Acid Monosodium Salt, Monohydrate, 97% (Titr.)
| 46506-88-1 |
|
4-Tert.-Butyl-Calix[4]arene-Crown-4-Complex
| 171058-95-0 |
|
4-Tert.-Butyl-Calix[4]Arene-Crown-5-Complex
| 99314-01-9 |
|
4-Tert.-Butyl-Calix[4]Arene-Crown-6-Complex
| 129518-51-0 |
|
2,3,4,5-Tetrafluoro-6-nitrobenzoic acid
| 16583-08-7 |
|
|